Is it time to say goodbye to weekly rituximab in ANCA vasculitis?

被引：0
|
作者：
Pinto, Benzeeta [1 ]
Dhooria, Aadhaar [2 ]
机构：
[1] St Johns Med Coll, Dept Clin Immunol & Rheumatol, Sarjapur Rd, Bengaluru 560034, India
[2] Santokba Durlabhji Mem Hosp, Dept Clin Immunol & Rheumatol, Jaipur, Rajasthan, India
来源：
CLINICAL RHEUMATOLOGY | 2020年 / 39卷 / 10期
关键词：
CYCLOPHOSPHAMIDE;
D O I：
10.1007/s10067-020-05360-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3153 / 3154
页数：2
相关论文
共 50 条
  • [31] Membranous Nephropathy with Proteinase 3-ANCA-associated Vasculitis Successfully Treated with Rituximab
    Yoshida, Shun
    Hanai, Shunichiro
    Nakagomi, Daiki
    Kobayashi, Kei
    Takahashi, Kazuya
    Furuya, Fumihiko
    INTERNAL MEDICINE, 2021, 60 (01) : 145 - 150
  • [32] Rituximab Induction and Maintenance in ANCA-Associated Vasculitis: State of the Art and Future Perspectives
    Treppo, Elena
    Binutti, Marco
    Agarinis, Roberto
    De Vita, Salvatore
    Quartuccio, Luca
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [33] Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients
    Wendt, M.
    Gunnarsson, I.
    Bratt, J.
    Bruchfeld, A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2012, 41 (02) : 116 - 119
  • [34] Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?
    Besada, Emilio
    Nossent, Johannes C.
    CLINICAL RHEUMATOLOGY, 2013, 32 (11) : 1677 - 1681
  • [35] ANCA associated vasculitis
    Hunter, Robert W.
    Welsh, Nicola
    Farrah, Tariq E.
    Gallacher, Peter J.
    Dhaun, Neeraj
    BMJ-BRITISH MEDICAL JOURNAL, 2020, 369
  • [36] Evolution of therapeutic management of patients with ANCA associated vasculitis in France after licensing Rituximab use
    Durel, Cecile-Audrey
    Thervet, Eric Simon
    Chauveau, Dominique
    Schmidt, Aurelie
    Terrier, Benjamin
    Bataille, Pierre M.
    BMC RHEUMATOLOGY, 2024, 8 (01)
  • [37] Successful Treatment of ANCA-Associated Vasculitis in the Setting of Common Variable Immunodeficiency Using Rituximab
    Hill, Frank
    Yonkof, Jennifer
    Arudra, Sri K. Chaitanya
    Thomas, Jean
    Altorok, Nezam
    AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (05) : E1239 - E1245
  • [38] Rituximab for Induction Therapy of ANCA-Associated Vasculitis: Practical Issues in the Asia Pacific Region
    Ho, Cheuk Man
    Mok, Chi Chiu
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2024, 27 (12)
  • [39] Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
    Bunch, Donna O'Dell
    McGregor, JulieAnne G.
    Khandoobhai, Nirmal B.
    Aybar, Lydia T.
    Burkart, Madelyn E.
    Hu, Yichun
    Hogan, Susan L.
    Poulton, Caroline J.
    Berg, Elisabeth A.
    Falk, Ronald J.
    Nachman, Patrick H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (03): : 382 - 391
  • [40] Rituximab use in patients with ANCA-associated vasculitis: clinical efficacy and impact on immunological parameters
    Chocova, Z.
    Hruskova, Z.
    Mareckova, H.
    Svobodova, B.
    Duskova, D.
    Bednarova, V.
    Jancova, E.
    Rysava, R.
    Tesar, V.
    CLINICAL RHEUMATOLOGY, 2015, 34 (01) : 107 - 115
12345